Does type of funding affect reporting in network meta-analysis? A scoping review of network meta-analyses.

ABSTRACT:

Background

Evidence has shown that private industry-sponsored randomized controlled trials (RCTs) and meta-analyses are more likely to report intervention-favourable results compared with other sources of funding. However, this has not been assessed in network meta-analyses (NMAs).

Objectives

To (a) explore the recommendation rate of industry-sponsored NMAs on their company's intervention, and (b) assess reporting in NMAs of pharmacologic interventions according to their funding type.

Methods

Design: Scoping review of published NMAs with RCTs.

Information sources

We used a pre-existing NMA database including 1,144 articles from MEDLINE, EMBASE and Cochrane Database of Systematic Reviews, published between January 2013 and July 2018.

Study selection

NMAs

SUBMITTER: Veroniki AA 

PROVIDER: S-EPMC10163730 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature